Polyol-based esters of hydroxycarboxylic acids
The invention relates to a method for producing polyol esters, especially polyglycerol esters, of 3-hydroxybutyric acid as well as the products thus obtained and their use.
1. A method for producing polyglycerol esters of
3-hydroxybutyric acid, the method comprising:
reacting at least one compound of the general formula (I)
CH 3 —CH(OH)—CH 2 —C(O)OR 1 (I)
wherein, in the general formula (I), the radical R 1 represents hydrogen or C 1 -C 4 -alkyl,
with at least one polyglycerol of the general formula (IIb)
HO—CH 2 —CH(OH)—CH 2 —[O—CH 2 —CH(OH)—CH 2 ] p —OH (IIb)
wherein, in the general formula (IIb), the variable p represents an integer from 1 to 4,
to obtain one or more 3-hydroxybutyric acid polyglycerol esters,
and a compound of the general formula (IV)
R 1 —OH (IV)
wherein, in the general formula (IV), the radical R 1 represents hydrogen or C 1 -C 4 -alkyl,
wherein the reaction is carried out in the absence of any solvents,
wherein the reaction is carried out in the presence of a catalyst, and
wherein the method further comprises continuously withdrawing the compound according to the general formula (IV) from the reaction.
2. The method according to claim 1 ,
wherein, the compound of the general formula (I) is 3-hydroxybutyric acid ethyl ester of the formula CH 3 —CH(OH)—CH 2 —C(O)OC 2 H 5 .
3. The method according to claim 1 ,
wherein the catalyst is selected from among enzymes and metal-containing catalysts; and
wherein the catalyst is recycled after the reaction.
4. The method according to claim 1 ,
wherein the compound of the general formula (I) and the polyglycerol (IIb) are used in a molar ratio of compound of the general formula (I)/polyglycerol (IIb) in a range of from 1:1 to 10:1.
5. The method according to claim 1 ,
wherein the polyglycerol (IIb) is a diglycerol of formula (IIc)
HO—CH 2 —CH(OH)—CH 2 —O—CH 2 —CH(OH)—CH 2 —OH (IIc).
6. The method according to claim 1 ,
wherein the reaction product obtained is fractionated after the reaction has been performed.
7. The method according to claim 1 ,
wherein unreacted starting compounds selected from among starting compounds (I) and (IIb) are separated from the reaction product and are subsequently recycled.
8. The method according to claim 1 ,
wherein the reaction is followed by an at least partial esterification of hydroxyl groups which are still present, wherein the esterification is carried out by reaction with a C 2 -C 30 -carboxylic acid anhydride.
9. A polyglycerol ester of 3-hydroxybutyric acid obtainable by the method according to claim 1 .
10. A polyglycerol ester of 3-hydroxybutyric acid,
wherein the polyglycerol ester of 3-hydroxybutyric acid corresponds to the general formula (IIIb)
R 2 O—CH 2 —CH(OR 2 )—CH 2 —[O—CH 2 —CH(OR 2 )—CH 2 ] p —OR 2 (IIIb)
wherein, in the general formula (IIIb),
the variable p represents an integer from 1 to 4,
R 2 , independently of one another, represents: hydrogen, a radical CH 3 —CH(OH)—CH 2 —C(O)— a radical CH 3 —CH(OR 3 )—CH 2 —C(O)— or a radical R 3 , however, with the proviso that at least one radical R 2 does not represent hydrogen, and with the proviso that at least one radical R 2 represents a radical CH 3 —CH(OH)—CH 2 —C(O)— or a radical CH 3 —CH(OR 3 )—CH 2 —C(O)—, and
R 3 represents the radical (C 1 -C 29 -alkyl)-C(O)—.
11. The polyglycerol ester of 3-hydroxybutyric acid according to claim 10
wherein, in the general formula (IIIb), R 2 , independently of one another, represents hydrogen or a radical CH 3 —CH(OH)—CH 2 —C(O)—, however, with the proviso that at least one radical R 2 does not represent hydrogen.
12. The polyglycerol ester of 3-hydroxybutyric acid according to claim 10 ,
wherein, in the general formula (IIIb), R 2 , independently of one another, represents: a radical CH 3 —CH(OH)—CH 2 —C(O)— a radical CH 3 —CH(OR 3 )—CH 2 —C(O)— or a radical R 3 , however, with the proviso that at least one radical R 2 represents a radical CH 3 —CH(OH)—CH 2 —C(O)— or a radical CH 3 —CH(OR 3 )—CH 2 —C(O)—, and
wherein, R 3 represents the radical (C 1 -C 29 -alkyl)-C(O)—.
13. The polyglycerol ester of 3-hydroxybutyric acid according to claim 10 ,
wherein the polyglycerol ester of 3-hydroxybutyric acid corresponds to general formula (IIIc),
R 2 O—CH 2 —CH(OR 2 )—CH 2 —O—CH 2 —CH(OR 2 )—CH 2 —OR 2 (IIIc)
wherein, in the general formula (IIIc), R 2 , independently of one another, represents: hydrogen, a radical CH 3 —CH(OH)—CH 2 —C(O)— a radical CH 3 —CH(OR 3 )—CH 2 —C(O)— or a radical R 3 , however, with the proviso that at least one radical R 2 does not represent hydrogen, and with the proviso that at least one radical R 2 represents a radical CH 3 —CH(OH)—CH 2 —C(O)— or a radical CH 3 —CH(OR 3 )—CH 2 —C(O)—, and
wherein R 3 represents the radical (C 1 -C 29 -alkyl)-C(O)—.
14. The polyglycerol ester of 3-hydroxybutyric acid according to claim 13 ,
wherein, in the general formula (IIIc), R 2 , independently of one another, represents hydrogen or a radical CH 3 —CH(OH)—CH 2 —C(O)—, however, with the proviso that at least one radical R 2 does not represent hydrogen.
15. The polyglycerol ester of 3-hydroxybutyric acid according to claim 13 ,
wherein, in the general formula (IIIc), R 2 , independently of one another, represents: a radical CH 3 —CH(OH)—CH 2 —C(O)— a radical CH 3 —CH(OR 3 )—CH 2 —C(O)— or a radical R 3 , however, with the proviso that at least one radical R 2 represents a radical CH 3 —CH(OH)—CH 2 —C(O)— or a radical CH 3 —CH(OR 3 )—CH 2 —C(O)—, and
wherein R 3 represents the radical (C 1 -C 29 -alkyl)-C(O)—.
16. A mixture comprising at least two different polyglycerol esters of 3-hydroxybutyric acid as defined in claim 10 .
17. A pharmaceutical composition,
wherein the pharmaceutical composition comprises at least one polyglycerol ester of 3-hydroxybutyric acid,
wherein the polyglycerol ester of 3-hydroxybutyric acid corresponds to the general formula (IIIb)
R 2 O—CH 2 —CH(OR 2 )—CH 2 —[O—CH 2 —CH(OR 2 )—CH 2 ] p —OR 2 (IIIb)
wherein, in the general formula (IIIb),
the variable p represents an integer from 1 to 4,
R 2 , independently of one another, represents: hydrogen, a radical CH 3 —CH(OH)—CH 2 —C(O)— a radical CH 3 —CH(OR 3 )—CH 2 —C(O)— or a radical R 3 , however, with the proviso that at least one radical R 2 does not represent hydrogen, and with the proviso that at least one radical R 2 represents a radical CH 3 —CH(OH)—CH 2 —C(O)— or a radical CH 3 —CH(OR 3 )—CH 2 —C(O)—, and
R 3 represents the radical (C 1 -C 29 -alkyl)-C(O)—.
18. The pharmaceutical composition according to claim 17 ,
wherein the pharmaceutical composition is a drug or a medicament.
19. A method of treating a human suffering from a disease associated with a disorder of the keto-body metabolism,
the method comprising a step of administering to said human a pharmaceutical composition comprising at least one polyglycerol ester of 3-hydroxybutyric acid,
wherein the polyglycerol ester of 3-hydroxybutyric acid corresponds to the general formula (IIIb)
R 2 O—CH 2 —CH(OR 2 )—CH 2 —[O—CH 2 —CH(OR 2 )—CH 2 ] p —OR 2 (IIIb)
wherein, in the general formula (IIIb),
the variable p represents an integer from 1 to 4,
R 2 , independently of one another, represents: hydrogen, a radical CH 3 —CH(OH)—CH 2 —C(O)— a radical CH 3 —CH(OR 3 )—CH 2 —C(O)— or a radical R 3 , however, with the proviso that at least one radical R 2 does not represent hydrogen, and with the proviso that at least one radical R 2 represents a radical CH 3 —CH(OH)—CH 2 —C(O)— or a radical CH 3 —CH(OR 3 )—CH 2 —C(O)—, and
R 3 represents the radical (C 1 -C 29 -alkyl)-C(O)—.
20. The method according to claim 19 ,
wherein the disease associated with a keto-body metabolism is selected from the group consisting of craniocerebral trauma, stroke, hypoxia, cardiovascular diseases, myocardial infarction, refeeding syndrome, anorexia, epilepsy, neurodegenerative diseases, dementia, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, fat metabolic diseases, glucose transporter defect (GLUT1 defect), VL-FAOD, mitochondriopathies, mitochondrial thiolase defect, Huntington's disease, cancers, T-cell lymphomas, astrocytomas, glioblastomas, HIV, rheumatic diseases, rheumatoid arthritis, arthritis urica, diseases of the gastrointestinal tract, chronic inflammatory bowel diseases, ulcerative colitis, Crohn's disease, lyosomal storage diseases, sphingolipidosis, Niemann-Pick disease, diabetes mellitus and effects of chemotherapy.
21. A food product,
wherein the food product comprises at least one polyglycerol ester of 3-hydroxybutyric acid,
wherein the polyglycerol ester of 3-hydroxybutyric acid corresponds to the general formula (IIIb)
R 2 O—CH 2 —CH(OR 2 )—CH 2 —[O—CH 2 —CH(OR 2 )—CH 2 ] p —OR 2 (IIIb)
wherein, in the general formula (IIIb),
the variable p represents an integer from 1 to 4,
R 2 , independently of one another, represents: hydrogen, a radical CH 3 —CH(OH)—CH 2 —C(O)— a radical CH 3 —CH(OR 3 )—CH 2 —C(O)— or a radical R 3 , however, with the proviso that at least one radical R 2 does not represent hydrogen, and with the proviso that at least one radical R 2 represents a radical CH 3 —CH(OH)—CH 2 —C(O)— or a radical CH 3 —CH(OR 3 )—CH 2 —C(O)—, and
R 3 represents the radical (C 1 -C 29 -alkyl)-C(O)—.